www.breastcancer-cured.com
Breast Cancer - Cured
Women for Breast Cancer Truth


    Good morning, distinguished members of the Mammography Awareness Group, good
    morning, dear Ladies. It is a pleasure and an honor to speak to you about methods of
    screening and diagnosing breast cancer.

    Some critics of mine stated in the past that I am against breast cancer screening. Nothing
    could be further from the truth. In every speech, lecture and interview I ever gave I
    always emphasized the urgent need to establish precise, accurate, and safe breast cancer
    screening, and to make such a screening system available to all women. Others said that I
    am dead set against mammography. In that, they were absolutely correct; I most certainly
    am.

    Someone might find it strange that I should appear in front of an activist group whose
    primary goal is to promote mammography. However, the observer would miss a vital point,
    because the primary goal of your group is not to promote, or oppose any specific
    technique or procedure. Your goal is to fight breast cancer, and you are promoting what
    you perceive as the best tools available for women.

    I have a profound respect for your aspirations, and will do my best to assist you in your
    fight. This lecture is offered as my contribution to your efforts.

    Mammography is being promoted by very powerful interest groups - including the
    international  oncological community - as the saviour of women. We are told that it is safe
    and effective. Here, in Italy, the overall compliance rate among women is approximately
    65% in 2007. In other words, two third of all Italian women participate in the
    mammogram screening program. This underlines the importance of determining just how
    safe and how effective this procedure is. What do research scientists say about it?

    Originally, the concept of mammography has been conceived in the United States.
    Interestingly, the USA is also the place where some very strong opposition to the
    procedure is voiced. Samuel S. Epstein, M.D., Chairman of the Cancer Prevention Coalition
    and Professor Emeritus of Environmental and Occupational Medicine, University of Illinois,
    has this to say about the efficacy of mammography:

    Mammography screening is a profit-driven technology posing risks compounded by
    unreliability. Contrary to popular belief and assurances by the U. S. media and the cancer
    establishment, mammography is not a technique for early diagnosis. In fact, a breast
    cancer has usually been present for about eight years before it can finally be detected.

    Danish researcher Dr. Peter Gotzsche, having analysed studies involving tens of thousands
    of women, found that mammograms not only produce unreliable results, but that they
    cause cancer in 10 to 20% of the patients screened. His conclusions were published in the
    "The Lancet" in October 2006. Dr. Gotzsche also quotes results from a study concerning,
    among other things, the informed consent of Italian women who underwent mammogram
    screenings. The authors of the study raised doubts about informed consent procedures
    since 68% of women believed screening reduced their risk of contracting breast cancer,
    62% that screening at least halved mortality, and 75% that 10 years of screening saved 10
    of 1000 participants, which is 10 times the most optimistic estimates. Other studies have
    shown that only 8% of women were aware that participation has the potential to harm
    healthy women, and that one third think screening detects more than 95% of breast
    cancers.

    His findings confirm the general opinion among medical analysts that in addition to failing
    to offer protection, mammograms — which involve exposing patients to cumulative
    radiation — do significantly increase women's risk of cancer.

    "The latest evidence shifts the balance towards harm and away from benefits," said Dr.
    Michael Baum of University College in London.

    According to Canadian columnist Dr. W. Gifford -Jones, women between the ages of 40
    and 49 who have regular mammograms are twice as likely to die from breast cancer as
    women who are not screened.

    According to some authorities, the squeezing of women's breasts during mammograms
    may rupture blood vessels, causing cancer to spread to other parts of the body and
    actually increasing a patient's risk of death. William Campbell Douglass, M.D., has said: "I
    find it maddeningly contradictory that medical students are taught to examine breasts
    gently to keep any possible cancer from spreading, yet radiologists are allowed to
    manhandle them for a mammogram." Dr. Epstein writes: Since 1928, physicians have
    been warned to handle "cancerous breasts with care -- for fear of accidentally
    disseminating cells" and spreading the cancer. Nevertheless, mammography entails tight
    and often painful breast compression, particularly in premenopausal women, which could
    lead to distant and lethal spread of malignant cells by rupturing small blood vessels in or
    around small undetected breast cancers.

    Different international studies show that mammograms fail to detect cancer 30-40 percent
    of the time in women aged 40 to 49. In addition, it can take eight years before a breast
    tumor is large enough to detect, by which time the cancer could have spread to other parts
    of the body. This, of course, destroys the credibility of the claim of an early detection, and
    the claim of prevention.

    In a study, published February 15, 2007 by the Dept of Diagnostic Radiology, Malmö
    University Hospital, Sweden, the authors finished saying, "We conclude on the basis of our
    experience that for every life saved between 1 and 2 women were overdiagnosed through
    screening."  A large percentage  of "overdiagnosed" women are talked into a completely
    needless mastectomy. (Overdiagnosis means: The false positive result of the application of
    diagnostic criteria that would not have given symptoms during the lifetime of a patient.)

    A USA National Cancer Insitute study found that approximately 33% of breast cancers
    detected by screening mammograms represent overdiagnosis.  Estimated to occur in 50%
    of women screened annually for 10 years, 25% of whom will have biopsies. Up to 46% of
    women with invasive cancer will have negative mammograms, especially if young, with
    dense breasts, or with mucinous, lobular, or fast-growing cancers. Concerning radiation
    hazard, the study states, "radiation-induced mutations can cause breast cancer, especially
    if exposed before age 30 years. Latency is more than 10 years, and the increased risk
    persists lifelong."  These difficult to find, and seldom mentioned data come from the
    American National Cancer Institute, that is one of the strong proponents of
    mammography. Isn't that remarkable? You can find this report on the internet if you go to
    Google, and type in the search term, <overdiagnosed breast cancer screening>.

    Switzerland has taken action, deciding not to offer a national mammography screening
    program. Dr. Gianfranco Domenighetti of the Swiss Network for Health Technology
    Assessment said the decision was heavily influenced by the Danish research, and by other
    international studies.

    What are the radiation risks of mammography?

    Radiation from routine mammography poses significant cumulative risks of initiating and
    promoting breast cancer. Contrary to conventional assurances that radiation exposure
    from mammography is trivial - and similar to that from a chest X-ray - about 1/ 1,000 of a
    rad (radiation-absorbed dose)- the routine practice of taking four films for each breast
    results in some 1,000-fold greater exposure, 1 rad, focused on each breast rather than the
    entire chest. Thus, premenopausal women undergoing annual screening over a ten-year
    period are exposed to a total of about 10 rads for each breast. As emphasized some three
    decades ago, the premenopausal breast is highly sensitive to radiation, each rad of
    exposure increasing breast cancer risk by 1 percent, resulting in a cumulative 10 percent
    increased risk over ten years of premenopausal screening (20 percent in case of twice-a-
    year screening), usually from ages 40 to 50; risks are even greater for "baseline"
    screening at younger ages, for which there is no evidence of any future relevance.
    Furthermore, breast cancer risks from mammography are up to fourfold higher for the 1 to
    2 percent of women who are silent carriers of the A-T (ataxia-telangiectasia) gene and
    thus highly sensitive to the carcinogenic effects of radiation.

    These are not trivial details, but statistically significant contributors to the rate of
    misdiagnosis, mutilation and mortality among Italian breast cancer patients.

    To sum it up:

    Mammography is not a technique for early diagnosis as breast cancer is rarely detectable
    by it until about eight years old.

    Evidence that screening allows early detection and treatment of breast cancer is tenuous
    based on analysis of two large trials. Danish researchers writing in the Lancet recently
    concluded: "There is no reliable evidence that screening decreases breast cancer mortality.
    Mammograph screening is unjustified."

    The Canadian National Breast Screening Study recently reported on a trial on some 39,000
    postmenopausal women. Half of the women performed monthly breast self-examination,
    following instruction by trained nurses, had annual clinical breast examinations by trained
    nurses and also annual mammograms. The others practiced self-exams and had annual
    clinical exams but no mammograms. The authors of the study concluded that the
    mammographic detection of non-palpable cancers did not improve survival rates.
    False-negative mammograms are particularly common in premenopausal women because
    of their denser breast structure, and also in postmenopausal women on estrogen
    replacement therapy as some develop breast densities, making mammograms difficult to
    read.

    About one-third of all breast cancers and more still of the aggressive premenopausal
    cancers are discovered in the interval between successive annual mammograms.
    Premenopausal women particularly can thus be lulled into a false sense of security and fail
    to seek medical advice.

    False-positive mammograms, common in premenopausal and postmenopausal women on
    estrogen replacement therapy, result in needless anxiety, additional mammograms or
    unnecessary biopsies - even mastectomies. For some, the cumulative risk of false positives
    can reach as high as 100 percent over a decade of screening.

    Screening poses cumulative cancer risks. The routine of taking four films for each breast
    results in one rad (radiation absorbed dose) exposure, about 1,000 times more than a
    chest X-ray. Less well recognized dangers are posed by forceful breast compression during
    premenopausal mammography, which may rupture blood vessels in or around small
    undetected cancers and result in the spread of malignant cells. A recent study of 663
    cancerous women published in the Archives of Surgery reveals that those subjects whose
    cancerous breast tumors were needle biopsied - in other words, intentionally
    ruptured for diagnostic purposes - were 50% more likely to subsequently develop cancer
    of the lymphatic nodes located under the armpit. I repeat: twice as likely to develop
    lymphatic cancer after disruption of the cancerous tumor. A mammogram procedure
    qualifies the description of unintentionally rupturing tumors for diagnostic purposes.

    Let me read you what, in the United States, Dr. Irwin J. D. Bross., Director of Biostatistics
    at Roswell Park Memorial Institute for Cancer Research commented about the cancer
    screening program:

    "The women should have been given the information about the hazards of radiation at the
    same time they were given the sales talk for mammography... Doctors were gung ho to use
    it on a large scale. They went right ahead and X rayed not just a few women but a quarter
    of a million women... A jump to the exposure of a quarter of a million persons to
    something which could do more harm than good was criminal and it was supported by
    money from the federal government and the American Cancer Society."

    In July 1995, the prestigious British medical journal The Lancet wrote:

    "The benefit is marginal, the harm caused is substantial, and the costs incurred are
    enormous..."

    Dr van der Horst, a radiologist in the Netherlands screening programme presented his
    findings to a meeting of European screening experts at the 4th European Breast Cancer
    Conference in Hamburg in March 2004.

    He was concerned that changing lifestyle patterns have resulted in more post-menopausal
    women having dense breast tissue. ‘This makes it harder for mammograms to pick up
    tumors or early signs of breast cancer and may lead to unnecessary biopsies because of
    uncertainties in reading the results’.

    His research took a random sample of 2,000 from 54,000 women, who are screened every
    two years in Holland.  The research classified the tissue as dense if more than a quarter of
    the tissue was dense.  Otherwise it was classified as lucent.

    The research found that 25 per cent of 50-69 year olds and 17 per cent of 65-69 year olds
    had dense breasts.

    They then looked at cancer rates, comparing total cancers with those detected by the
    mammograms, i.e. the ability of the mammogram to actually correctly detect a cancer.

    In the lucent group it was 67 per cent. (33% false negatives)
    In the dense group it was 59 per cent. (41% false negatives)

    If the statistical results of mammography are so poor, why is the protocol still in use? Your
    oncologist will say, "because there is nothing better, or even as good as mammography.
    It is still the best screening method for breast cancer." This, of course, is completely false.
    There are several better methods available. The most sensitive and reliable is
    thermography. It is safe, accurate, legal, and it has been around since over 30 years. It is
    able to detect cancer formation in the breast 8-10 years earlier than mammography, MRI,
    PETscan, etc. It is a non-invasive, gentle procedure, with no radiation involved.

    Why is oncology steadfast in its refusal to recognize the superior performance of
    thermography, as well as the dangers and the unreliability of mammography? This, I am
    afraid, is a question that is beyond the scope of this lecture.

    Thank you for your attention, and for the opportunity to share this information with you.
    If you have questions, I will be glad to hear them.

    (Question/Answer period follows)
Mammography:
Myths versus Facts
Fabrizio Taliano MD, PhD.

Spoken  in February, 2007
before the members of a
Mammography Awareness Group
in Rome
LECTURE 4 (excerpts)